vTv Therapeutics (VTVT) Shares Outstanding (Diluted) (2015 - 2026)
vTv Therapeutics (VTVT) reported Weighted Average Shares Outstanding (Diluted) of 12.41 million for Q2 2026, up 88.4% from 6.59 million a year earlier but down 15.2% from the prior quarter.
Powered by 
Analysis
vTv Therapeutics (VTVT) Shares Outstanding (Diluted) (2015 - 2026) Analysis & Trends
For FY2025, vTv Therapeutics posted Weighted Average Shares Outstanding (Diluted) of 8.42 million, up 46.0% from FY2024.
- Weighted Average Shares Outstanding (Diluted) has increased for five consecutive years, with a five-year compound annual growth rate of 48.2% (FY2020 to FY2025).
- By year, Weighted Average Shares Outstanding (Diluted) came in at 5.77 million in FY2024 (+176.8%), 2.08 million in FY2023 (+11.4%), 1.87 million in FY2022 (+23.3%) and 1.52 million in FY2021 (+28.8%).
- Five-year quarterly Weighted Average Shares Outstanding (Diluted) spans a low of 1.52 million in Q4 2021 and a high of 14.63 million in Q1 2026.
- Year over year, Weighted Average Shares Outstanding (Diluted) has now increased in each of the last 19 quarters, with growth averaging 88.8% over the last eight quarters.
- Across the past five years, year-over-year growth in Weighted Average Shares Outstanding (Diluted) ran from 1.2% in Q3 2023 to 214.3% in Q2 2024.
- Per Business Quant data, the three quarters before Q2 2026 came in at 14.63 million (Q1 2026), 8.42 million (Q4 2025) and 8.06 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | vTv Therapeutics | 260.90 Mn | -89.97 Mn | - | 12.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 12.42 Mn |
| Jun 30, 2026 | 12.41 Mn |
| Mar 31, 2026 | 14.63 Mn |
| Dec 31, 2025 | 8.42 Mn |
| Sep 30, 2025 | 8.06 Mn |
| Jun 30, 2025 | 6.59 Mn |
| Mar 31, 2025 | 6.58 Mn |
| Dec 31, 2024 | 5.77 Mn |
| Sep 30, 2024 | 5.46 Mn |
| Jun 30, 2024 | 6.40 Mn |
| Mar 31, 2024 | 4.14 Mn |
| Dec 31, 2023 | 2.08 Mn |
| Sep 30, 2023 | 81.48 Mn |
| Jun 30, 2023 | 81.48 Mn |
| Mar 31, 2023 | 81.48 Mn |
| Dec 31, 2022 | 74.88 Mn |
| Sep 30, 2022 | 80.49 Mn |
| Jun 30, 2022 | 70.37 Mn |
| Mar 31, 2022 | 3,190.00 |
| Dec 31, 2021 | 4,410.00 |
API Access
vTv Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=VTVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "VTVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=VTVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();